Literature DB >> 19122397

Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection.

Tomomi Takano1, Chisako Kawakami, Shinji Yamada, Ryoichi Satoh, Tsutomu Hohdatsu.   

Abstract

Feline infectious peritonitis virus (FIPV) is classified into serotype I and serotype II according to the amino acid sequence of its spike(S) protein. Antibody dependent enhancement (ADE) of macrophage infection occurs in the presence of antibodies to FIPV S protein, and a close relationship between ADE and neutralizing epitopes has been reported. The importance of differences in FIPV serotype on the induction of ADE remains unclear. In this study, we investigated whether the same or different serotype of FIPV induces ADE in cats. Specific pathogen-free cats were passively immunized with anti-type I or II FIPV antibodies, and we investigated the induction of ADE following subcutaneous inoculation with type I FIPV. Inoculation using FIPV serotype I enhanced the onset of FIP in cats passively immunized with FIPV serotype I-specific antibodies but not in those passively immunized with antibodies to FIPV serotype II. These data suggest that re-infection with the same serotype induces ADE in cats infected with FIPV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19122397     DOI: 10.1292/jvms.70.1315

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  44 in total

1.  Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.

Authors:  Gang Wang; Guangli Hu; Rui Liang; Jiale Shi; Xiuxiu Qiu; Yiling Yang; Zhe Jiao; Yixi Chen; Zhou Shen; Mengxia Li; Yuejun Shi; Junfu Mao; Guiqing Peng
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

2.  Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes.

Authors:  Patrick Guérin; Nouara Yahi; Fodil Azzaz; Henri Chahinian; Jean-Marc Sabatier; Jacques Fantini
Journal:  Molecules       Date:  2022-06-15       Impact factor: 4.927

3.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

4.  Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.

Authors:  Hans-Georg Rammensee; Cécile Gouttefangeas; Sonja Heidu; Reinhild Klein; Beate Preuß; Juliane Sarah Walz; Annika Nelde; Sebastian P Haen; Michael Reth; Jianying Yang; Ghazaleh Tabatabai; Hans Bösmüller; Helen Hoffmann; Michael Schindler; Oliver Planz; Karl-Heinz Wiesmüller; Markus W Löffler
Journal:  Vaccines (Basel)       Date:  2021-04-24

5.  Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death.

Authors:  Laszlo Szekely; Bela Bozoky; Matyas Bendek; Masih Ostad; Pablo Lavignasse; Lars Haag; Jieyu Wu; Xu Jing; Soham Gupta; Elisa Saccon; Anders Sönnerborg; Yihai Cao; Mikael Björnstedt; Attila Szakos
Journal:  Heliyon       Date:  2021-05-24

Review 6.  Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages.

Authors:  Pureum Lee; Chang-Ung Kim; Sang Hawn Seo; Doo-Jin Kim
Journal:  Immune Netw       Date:  2021-02-26       Impact factor: 6.303

7.  The paradox of feline coronavirus pathogenesis: a review.

Authors:  Luciana Wanderley Myrrha; Fernanda Miquelitto Figueira Silva; Ethel Fernandes de Oliveira Peternelli; Abelardo Silva Junior; Maurício Resende; Márcia Rogéria de Almeida
Journal:  Adv Virol       Date:  2011-08-21

8.  Passive immunization does not provide protection against experimental infection with Mycoplasma haemofelis.

Authors:  Sarah Sugiarto; Andrea M Spiri; Barbara Riond; Marilisa Novacco; Angelina Oestmann; Luisa H Monteiro de Miranda; Marina L Meli; Felicitas S Boretti; Regina Hofmann-Lehmann; Barbara Willi
Journal:  Vet Res       Date:  2016-08-05       Impact factor: 3.683

9.  In vitro antiviral activity of circular triple helix forming oligonucleotide RNA towards Feline Infectious Peritonitis virus replication.

Authors:  Oi Kuan Choong; Parvaneh Mehrbod; Bimo Ario Tejo; Abdul Rahman Omar
Journal:  Biomed Res Int       Date:  2014-02-20       Impact factor: 3.411

10.  Crystallization and preliminary crystallographic study of Feline infectious peritonitis virus main protease in complex with an inhibitor.

Authors:  Jinshan Wang; Fenghua Wang; Yusheng Tan; Xia Chen; Qi Zhao; Sheng Fu; Shuang Li; Cheng Chen; Haitao Yang
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.